Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception

Human Reproduction

Volumn 25, Issue 2, 2010, Pages 360-367

  Hester, Kim E ^a   Harper, Michael J K ^b   Duffy, Diane M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

COX 2 inhibitor; Follicle; Monkey; Ovulation; Prostaglandin

Indexed keywords

ESTRADIOL; LUTEINIZING HORMONE; MELOXICAM; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EMERGENCY CONTRACEPTION; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILE PERIOD; FOLLICULAR PHASE; HORMONAL REGULATION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MACACA; MENSTRUAL CYCLE; MENSTRUATION; NONHUMAN; OOCYTE; OVARY FOLLICLE; OVULATION INHIBITION; PROGESTERONE BLOOD LEVEL; TREATMENT DURATION;

ANIMALIA; MACACA FASCICULARIS; PRIMATES;

EID: 74549127497     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep424     Document Type: Article

References (46)

1. Akil M, Amos RS, Stewart P. Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol 1996;35:76-78.
2. Albrecht ED, Aberdeen GW, Pepe GJ. The role of estrogen in the maintenance of primate pregnancy. Am J Obstet Gynecol 2000; 182:432-438.
3. Armstrong DT, Grinwich DL. Blockade of spontaneous and LH-induced ovulation in rats by indomethacin, an inhibitor of prostaglandin biosynthesis. Prostaglandins 1972;1:21-28.
4. Bata MS, Al-Ramahi M, Salhab AS, Gharaibeh MN, Schwartz J. Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study. J Clin Pharmacol 2006;46:925-932.
5. Chaffin CL, Hess DL, Stouffer RL. Dynamics of periovulatory steroidogenesis in the rhesus monkey follicle after controlled ovarian stimulation. Hum Reprod 1999;14:642-649.
6. Chang L, Gulmezoulu AM, Piaggio G, Excurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev 2008:CD001324.
7. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24:428-465.
8. Duffy DM, Stouffer RL. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod 2001;7:731-739.
9. Duffy DM, Stouffer RL. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod 2002;17:2825-2831.
10. Duffy DM, Dozier BL, Seachord CL. Prostaglandin dehydrogenase (PGDH) and prostaglandin levels in periovulatory follicles: implications for control of primate ovulation by PGE2. J Clin Endocrinol Metab 2005;90:1021-1027.
11. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999;13:1035-1048.
12. Eppig JJ. Prostaglandin E2 stimulates cumulus expansion and hyaluronic acid synthesis by cumuli oophori isolated from mice. Biol Reprod 1981; 25:191-195.
13. Freeman ME. The ovarian cycle of the rat. In: Knobil E, Neill JD (ed). The Physiology of Reproduction, New York: Raven Press, 1988. 1893-1928.
14. Goodman AL, Hodgen GD. Menstrual cycle characteristics in chronically hemiovariectomized cynomolgus monkeys (Macaca fascicularis). J Clin Endocrinol Metab 1979;48:345-347.
15. Graff J, Skarka C, Klinkhardt U, Watzer B, Harder S, Seyberth H, Geisslinger G, Nusing RM. Effects of selective COX-2 inhibition on prostanoids and platlet physiology in young healthy volunteers. J Thromb Haemost 2007;5:2376-2385.
16. Helin-Salmivaara A, Virtanen A, Vesalainen R, Gronroos JM, Klaukka T, Idanpaan-Heikkila JE, Huupponen R. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 2006; 27:1657-1663.
17. Hizaki H, Segi E, Sugimoto Y, Hirose M, Saji T, Ushikubi F, Matsuoka T, Noda Y, Tanaka T, Yoshida N et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP 2. Proc Natl Acad Sci USA 1999;96:10501-10506.
18. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-7388.
19. Jesam C, Salvatierra AM, Schwartz J, Croxatto HB. Suppresion of follicular rupture with meloxicam, a cyclooxygenase inhibitor. Potential for emergency contraception. Hum Reprod 2009; [Epub ahead of print].
20. Killick S, Elstein M. Pharmacologic production of luteinized unruptured follicles by prostagladin synthetase inhibitors. Fertil Steril 1987; 47:773-777.
21. Layton D, Heeley E, Hughes K, Shakir SAW. Comparison of the incidence rates of thromoembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data. Rheumatology 2003a; 42:1342-1353. (Pubitemid 37407026)
22. Layton D, Hughes K, Harris S, Shakir SAW. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data. Rheumatology 2003b; 42:1354-1364. (Pubitemid 37407027)
23. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997;91:197-208.
24. Luna LG. Manual of histologic staining methods of the armed forces institute of pathology. New York: McGraw Hill, 1968.
25. Markosyan N, Duffy DM. Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology 2009;150:435-444.
26. Mendonca LL, Khamashta MA, Nelson-Piercy C, Hunt BJ, Hughes GR. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) 2000;39:880-882.
27. Mikuni M, Pall M, Peterson CM, Hellberg P, Brannstrom M, Richards JS, Hedin L. The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol Reprod 1998;59:1077-1083.
28. Murdoch WJ. Differential effects of indomethacin on the sheep ovary: prostaglandin biosynthesis, intracellular calcium, apoptosis, and ovulation. Prostaglandins 1996;52:497-506.
29. Murdoch WJ, Peterson TA, Van Kirk EA, Vincent DL, Inskeep EK. Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe. Biol Reprod 1986;35:1187-1194.
30. Niswender GD, Spies HG. Serum levels of luteinizing hormone, follicle-stimulating hormone and progesterone throughout the menstrual cycle of rhesus monkeys. J Clin Endocrinol Metab 1973; 37:326-328.
31. Noble S, Balfour JA. Meloxicam. Drugs 1996;51:424-432.
32. Ochsner SA, Russell DL, Day AJ, Breyer RM, Gomer RH, Richards JS. Decreased expression of tumor necrosis factor-a-stimulated gene 6 in cumulus cells of the cyclooxygenase-2 and EP2 null mice. Endocrinology 2003;144:1008-1019.
33. Pall M, Friden BE, Brannstrom M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: A randomized double-blind study. Hum Reprod 2001;16:1323.
34. Peters MW, Pursley JR, Smith GW. Inhibition of intrafollicular PGE2 synthesis and ovulation following ultrasound-mediated intrafollicular injection of the selective cyclooxygenase-2 inhibitor NS-398 in cattle. J Anim Sci 2004;82:1656-1662.
35. Reich R, Daphna-Iken D, Chun SY, Popliker M, Slager R, Adelmann-Grill BC, Tsafriri A. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids. Endocrinology 1991;129:1869-1875.
36. Richards JS. Editorial: sounding the alarm-does induction of prostagladin endoperoxide synthase-2 control the mammalian ovulatory clock? Endocrinology 1997;138:4047-4048.
37. Rothchild I. The regulation of the mammalian corpus luteum. Recent Prog Horm Res 1981;37:183-298.
38. Sirois J. Induction of prostaglandin endoperoxide synthase-2 by human chorionic gonadotropin in bovine preovulatory follicles in vivo. Endocrinology 1994;135:841-848.
39. Sirois J, Dore M. The late induction of prostaglandin G/H synthase-2 in equine preovulatory follicles supports its role as a determinant of the ovulatory process. Endocrinology 1997;138:4427-4434.
40. Smith WL. Molecular biology of prostanoid biosynthetic ezymes and receptors. Adv Exp Med Biol 1997;400B:989-1011.
41. Stewart F, Trussell J, Van Look PFA. Emergency contraception. In: Hatcher RA, Trussell J, Nelson AL et al. (ed.), Contraceptive Technology. New York: Ardent Media Inc., 2007. 87-116.
42. Von Hertzen H, Godfrey M. Emergency contraception: the state of the art. Reprod Biomed Online 2009;18:28-31.
43. Wallach EE, de la Cruz A, Hunt J, Wright KH, Stevens VC. The effect of indomethacin on hMG-hCG induced ovulation in the rhesus monkey. Prostaglandins 1975;9:645-658.
44. Weick RF, Dierschke DJ, Karsch FJ, Butler WR, Hotchkiss J, Knobil E. Periovulatory time course of circulating gonadotropic and ovarian hormones in the rhesus monkey. Endocrinology 1973;93:1140-1147.
45. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. N Engl J Med 1995;333:1517-1521.
46. Wong WYL, Richards JS. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol Endocrinol 1991;5:1269-1279.